Q-omics provides the consensus-scored PRELID3BP2 profile across patient tissues and cancer cell-line models. PRELID3BP2 expression is associated with patient survival in 7 of 34 cancer types, with the highest sampling consensus in STAD. Additionally, PRELID3BP2 RNA expression shows 5,270 significant gene co-expression associations, with the highest sampling consensus in LUSC. Together, these results highlight STAD, and LUSC as cancer lineages where PRELID3BP2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for PRELID3BP2 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes PRELID3BP2 survival associations across molecular data types. PRELID3BP2 RNA expression shows survival associations in the most cancer types (7). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

PRELID3BP2 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	7	STAD (162)	view →

This table ranks reproducible PRELID3BP2 RNA expression–survival associations across cancer types. High PRELID3BP2 expression shows unfavorable associations in STAD, OV, KIRC, READ, KIRP and LGG. The STAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify STAD as the clearest survival context for PRELID3BP2 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	II,III,IV	0.470	0.682	<.001	162	view →
OV	OS	Tertile	II,III,IV	0.321	0.845	<.001	108	view →
KIRC	OS	Tertile	All	0.208	0.633	<.001	84	view →
READ	OS	Tertile	All	0.685	0.932	.001	30	view →
KIRP	DFS	Tertile	All	0.157	0.867	<.001	27	view →
LGG	OS	Tertile	All	0.569	0.815	.023	12	view →

Pink = unfavorable, green = favorable. all 7 lineages →

PRELID3BP2-STAD (OS)

Kaplan–Meier survival curve for PRELID3BP2 RNA expression in STAD: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with PRELID3BP2 in patient tissues and cancer cell lines. In patient samples, PRELID3BP2 shows the broadest associations at the RNA and protein expression levels, with LUSC recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	5,270	LUSC (2598)	view →
Mutation	713	READ (404)	view →